[1] Guo Z, Jiang JH, Zhang J, et al. Side population in hepatocellular carcinoma HCCLM3 cells is enriched with stem-like cancer cells.. Oncol Lett, 2016, 11:3145-3151.
[2] 胡志超, 金浩生, 林叶,等. 乙型肝炎相关性肝癌术后抗病毒治疗的临床意义. 肝脏, 2015:18-20.
[3] Ryser S, Dizin E, Jefford CE, et al. Distinct roles of BARD1 isoforms in mitosis: full-length BARD1 mediates Aurora B degradation, cancer-associated BARD1beta scaffolds Aurora B and BRCA2. Cancer Res, 2009, 69:1125-1134.
[4] 陈霖. BARD1蛋白在肿瘤中作用的研究进展. 肿瘤研究与临床, 2014, 26:497-499.
[5] 中国抗癌协会肝癌专业委员会. 原发性肝癌诊断标准. 中华肝脏病杂志, 2000, 8:135.
[6] Sporn JC, Hothorn T, Jung B. BARD1 expression predicts outcome in colon cancer. Clinical Cancer Res J Am Associ Cancer Res, 2011, 17:5451.
[7] Mcmahon BJ, Bruden D, Townshendbulson L, et al. Infection with hepatitis C virus genotype 3 is an independent risk factor for end-stage liver disease, hepatocellular carcinoma, and liver-related death. Clin Gastroenterol Hepatol, 2017, 15:431-437.
[8] 张相国, 梁思贤, 潘素明,等. 基于MRI的淋巴结包膜侵犯与鼻咽癌3DRT的预后关系. 中华放射肿瘤学杂志, 2017, 26:621-626.
[9] 王建民, 吕铁升. 原发性肝癌手术切除患者预后危险因素分析. 现代肿瘤医学, 2010, 18:523-525.
[10] 杨薇, 陈敏华, 严昆,等. 肝细胞癌射频治疗总生存率及无瘤生存率探讨. 中国医学影像技术, 2006, 22:121-124.
[11] 周延岩, 许鑫森, 王志鑫,等. 肿瘤直径与肝细胞癌肝切除患者预后的关系. 中华肝脏外科手术学电子杂志, 2015,7:227-231.
[12] 党存曙, 刘大鹏, 赵孟杰, 等. 不同TNM分期肝癌患者微血管密度与肿瘤标志物水平相关性研究. 河北医药, 2017,2:11-15.
[13] 王瑞涛, 李建波, 张灵强, 等. 原发性肝癌淋巴结转移临床病理特点与预后的关系. 中华消化外科杂志.2015,14:127-132. |
